Bengaluru based Sami-Sabinsa Group has strengthened its market position in Canada with the grant of three new patents.
Patent CA2976689 is for an invention for a water-soluble form of Curcumin, which Sami-Sabinsa sells under the brand named uC3 Clear®. The patent discloses a method of solubilising curcuminoids using polyvinyl pyrrolidone and sodium bis (2-ethylhexyl) sulfosuccinate. The aqueous solubility of curcumin/curcuminoid mixtures is enhanced to more than 10-15 per cent w/v in water. Sami-Sabinsa developed this product to solve solubility challenges with use of curcumin in functional beverages.
Another new patent, CA2979287, is for the anti-cancer properties of a compound - (E)-4-(3’, 4’-Dimethoxyphenyl) but-1,3-diene (DMBPD), isolated from Thai ginger (Zingiber cassumunar). The patent discloses a concentration-dependent in-vitro anti-tumorigenic activity of (E)-1-(3,4-dimethoxyphenyl) butadiene on cancer cells (pancreatic, prostate and ovarian carcinoma). This invention has also been granted patents in the USA (US 9,833,422, US 9,913,809), Australia (AU2016385393), Russia (RU2694053), New Zealand (NZ735027) and Japan (JP 6584526).
The third new patent granted in Canada (CA2975170) is on the use of OLEPENT® cosmetic peptides in maintaining water hydration by increasing the expression of a water channel protein called aquaporin 5 (AQP5). The patent describes the increase in expression of genes and associated proteins for improving skin barrier function in hydration deficient human skin, using OLEPENT®.
One such peptide is the C-terminal fragment of collagen 1, which constitutes the peptide Lys-Thr-Thr-Lys-Ser and can stimulate the synthesis of collagen.
Sami-Sabinsa also attained an NPN for its uC3 CLEAR composition for the Canadian Natural Health Products market with these claims:
- Provides antioxidants for maintenance of good health
- Used in herbal medicine to help relieve joint inflammation
“Our commitment to research and development is continuing to bring innovations that consumers can soon enjoy,” said Dr Muhammed Majeed, Founder and Chairman Sami-Sabinsa. “These patents provide the added assurance that low quality copycats won’t easily disrupt the marketplace, which protects our customers.”